S-1/A: Enveric Biosciences Files Amendment No. 2 to Form S-1 Registration Statement

Enveric Biosciences has filed an amendment to its S-1 registration statement, primarily to include updated exhibits related to its financial and legal agreements.

Summary

• Enveric Biosciences filed Amendment No. 2 to its Form S-1 registration statement with the Securities and Exchange Commission on January 30, 2025.
• The primary purpose of this amendment is to include Exhibits 1.1, 1.2, and 23.2, which relate to an engagement letter with H.C. Wainwright & Co., LLC, an amendment to that letter, and the consent of the independent auditor, Marcum LLP.
• No changes were made to the preliminary prospectus or other items in Part II of the registration statement, except for the addition of the exhibits.
• The company is seeking to register securities for sale to the public, with the commencement date to be determined after the effective date of the registration statement.
• The company has engaged H.C. Wainwright & Co., LLC as the exclusive underwriter, agent, or advisor for any securities offering during the term of the agreement.
• The agreement includes a cash fee of 7.0% of gross proceeds for underwritten offerings and 3.0% for at-the-market (ATM) offerings, as well as warrant coverage and expense allowances.
• The company has also agreed to a right of first refusal for Wainwright for future financings within 12 months of any offering.
• The term of the engagement is initially 90 days, extendable by another 90 days if an offering is completed within the initial term.
• The amendment to the engagement letter reduces the non-accountable expense allowance from $35,000 to $25,000 for the specific offering related to the S-1 filing.
• Marcum LLP has provided its consent to the inclusion of their audit report in the registration statement, with an updated date of January 30, 2025, for matters added in notes 1 and 12.

Sentiment

Score: 7

Explanation: The document is a standard regulatory filing related to a capital raise, which is generally positive for the company's growth prospects. The terms of the engagement are typical, but the fees and warrants could be a slight negative. Overall, the sentiment is moderately positive.

Positives

• The company has secured an exclusive underwriter, agent, or advisor in H.C. Wainwright & Co., LLC, which could facilitate future capital raising.
• The engagement letter outlines clear terms for compensation and expenses, providing transparency for both parties.
• The company has obtained the necessary consent from its independent auditor, Marcum LLP, for the inclusion of their audit report in the registration statement.

Negatives

• The company is obligated to pay a significant percentage of gross proceeds as fees to Wainwright, which could reduce the net capital raised.
• The company is subject to a right of first refusal for Wainwright for future financings, which could limit its options.
• The company is obligated to pay Wainwright's expenses even if an offering is not completed.

Risks

• The success of any offering is subject to market conditions and is not guaranteed by Wainwright's engagement.
• The company is obligated to pay fees and expenses to Wainwright even if an offering is not completed.
• The company is subject to a tail provision, which requires compensation to Wainwright for financings within 12 months of the agreement's termination if Wainwright introduced the investors.
• The company is subject to a right of first refusal for Wainwright for future financings, which could limit its options.

Future Outlook

The company intends to commence a public offering of securities as soon as practicable after the effective date of the registration statement.

Management Comments

• Joseph Tucker, Ph.D., Chief Executive Officer, is the contact person for the company regarding the engagement with H.C. Wainwright & Co., LLC.

Industry Context

The engagement of an underwriter like H.C. Wainwright & Co., LLC is a common step for companies seeking to raise capital through public or private offerings. The terms of the agreement, including fees and warrant coverage, are typical for such engagements in the financial industry.

Comparison to Industry Standards

• The 7% cash fee for underwritten offerings is within the typical range for smaller cap companies, although it can be considered high.
• The 3% fee for ATM offerings is also within the standard range for such facilities.
• The warrant coverage of 7% is a common incentive for underwriters, but the specific terms can vary.
• The expense allowances are also typical, although the reduction in non-accountable expenses for this specific offering is a minor deviation.
• The right of first refusal is a common clause in such agreements, but it can limit the company's flexibility in future financings.
• The tail provision is also standard, ensuring the underwriter is compensated for their efforts even after the agreement's termination.

Stakeholder Impact

• Shareholders may see potential dilution from the issuance of new shares and warrants.
• Employees may benefit from the company's ability to raise capital for growth and development.
• Customers may see improved products and services as a result of the capital raise.
• Suppliers may see increased business opportunities with the company.
• Creditors may see improved financial stability of the company.

Next Steps

• The company will proceed with the registration process with the SEC.
• The company will work with H.C. Wainwright & Co., LLC to prepare for the securities offering.
• The company will determine the commencement date for the public offering after the effective date of the registration statement.

Key Dates

Keywords

Registration Statement, Securities Offering, Underwriter, H.C. Wainwright, Warrants, Engagement Letter, Capital Raise, Financial Agreement, Marcum LLP, Auditor Consent